Skip to content

Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm

Women's Health Initiative Memory Study of Younger Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01124773
Acronym
WHIMS-Y
Enrollment
1362
Registered
2010-05-17
Start date
2009-06-30
Completion date
2016-06-30
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

cognition, memory, hormone therapy

Brief summary

WHIMS-Y provides valuable information on the long-term effects on risk of cognitive impairment of hormone therapy in a subset of WHI participants in the WHI Hormone Trials. Following cessation of study-prescribed HT cognitive function and impairment were assessed.

Detailed description

The Women's Health Initiative Memory Study of Younger Women (WHIMS-Y) is proposed to assess the long-term impact of random assignment to postmenopausal hormone therapy (equine estrogen alone or in combination with medroxyprogesterone versus placebo) among women who were aged 50-54 at the time of randomization into the WHI hormone trials. Secondary objectives relate to the consistency of any treatment effects across unopposed or opposed therapy and whether there exists evidence of graded relationships between cognitive effects and age of administration, years from menopause, and baseline risk factors for cognitive impairment.

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 54 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be enrolled in the Women's Health Initiative Extension

Exclusion criteria

* Not enrolled in the Women's Health Initiative Extension

Design outcomes

Primary

MeasureTime frameDescription
All-cause dementia and Mild Cognitive ImpairmentMeasured once a yearParticipants will have a cognitive assessment administered over the telephone.

Secondary

MeasureTime frameDescription
Global and domain specific cognitive function.Measured once a yearParticipants will have a cognitive assessment administered over the telephone.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026